Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | potassium voltage-gated channel, shaker-related subfamily, member 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | shaker cognate | potassium voltage-gated channel, shaker-related subfamily, member 3 | 575 aa | 465 aa | 34.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.0478 | 0.0186 |
Echinococcus granulosus | potassium voltage gated channel protein | 0.0104 | 0.0478 | 0.0478 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Brugia malayi | hypothetical protein | 0.0369 | 0.6147 | 0.6147 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.034 | 0.5536 | 0.5581 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Schistosoma mansoni | hypothetical protein | 0.0446 | 0.7801 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0096 | 0.0304 | 0.0304 |
Brugia malayi | hypoxia-induced factor 1 | 0.034 | 0.5536 | 0.5536 |
Loa Loa (eye worm) | hypothetical protein | 0.0369 | 0.6147 | 0.6233 |
Echinococcus multilocularis | potassium voltage gated channel subfamily A | 0.0099 | 0.0381 | 0.0381 |
Mycobacterium ulcerans | putative regulatory protein | 0.0081 | 0 | 0.5 |
Schistosoma mansoni | single-minded | 0.011 | 0.0611 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0.9678 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0549 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0431 | 0.7479 | 0.7479 |
Brugia malayi | PAS domain containing protein | 0.011 | 0.0611 | 0.0611 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0549 | 1 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily A | 0.0104 | 0.0478 | 0.0478 |
Echinococcus multilocularis | jun protein | 0.0549 | 1 | 1 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.011 | 0.0611 | 0.041 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0104 | 0.0478 | 0.0233 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0104 | 0.0478 | 0.0478 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0096 | 0.0304 | 0.0304 |
Onchocerca volvulus | 0.0431 | 0.7479 | 1 | |
Brugia malayi | Voltage-gated potassium channel, Shaker-family (KCNA, Kv1-like) alpha-subunit | 0.0104 | 0.0478 | 0.0478 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0104 | 0.0478 | 0.0233 |
Echinococcus granulosus | jun protein | 0.0549 | 1 | 1 |
Schistosoma mansoni | jun-related protein | 0.0446 | 0.7801 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 99 nM | Inhibition of DiTc binding to Kv1.3 channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (binding) | = 99 nM | Inhibition of DiTc binding to Kv1.3 channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (binding) | = 104 nM | Inhibition of DiTc binding to Kv1.x channel in human brain membranes | ChEMBL. | 12643934 |
IC50 (functional) | = 150 nM | Inhibition of [86Rb+] efflux from CHO cells stably transfected with Kv1.3 channel | ChEMBL. | 12643934 |
IC50 (functional) | = 150 nM | Inhibition of [86Rb+] efflux from CHO cells stably transfected with Kv1.3 channel | ChEMBL. | 12643934 |
IC50 (functional) | = 1255 nM | Inhibition of T-cell proliferation was determined by a human T-cell assay | ChEMBL. | 12643934 |
IC50 (functional) | = 1255 nM | Inhibition of T-cell proliferation was determined by a human T-cell assay | ChEMBL. | 12643934 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.